Intuitive Surgical, Inc. (LON: 0R29)

Market Cap	148.57B
Revenue (ttm)	5.87B
Net Income (ttm)	1.67B
Shares Out	n/a
EPS (ttm)	4.64
PE Ratio	88.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4
Open	527.82
Previous Close	528.27
Day's Range	527.33 - 527.82
52-Week Range	232.27 - 527.82
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 21, 2025

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and cor...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 13,676
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R29

Financial Performance

In 2023, Intuitive Surgical's revenue was $7.12 billion, an increase of 14.49% compared to the previous year's $6.22 billion. Earnings were $1.80 billion, an increase of 35.98%.

Financial numbers in USD